AVTR
Avantor, Inc.
Company overview
- Market capitalization
- $10.34B
- Employees
- 13,500
- Latest publication
- 2026-09-29
About Avantor, Inc.
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, and fluid handling tips. It also provides equipment and instrumentation products, including filtration systems, virus inactivation systems, incubators, analytical instruments, evaporators, ultra-low-temperature freezers, biological safety cabinets, peristaltic pumps, and critical environment supplies. In addition, the company offers services and specialty procurements comprising onsite lab and production, equipment, procurement and sourcing, and biopharmaceutical material scale-up and development services. Further, it provides scientific research support services, such as DNA extraction, bioreactor servicing, clinical and biorepository, compound management, cleanroom control, monitoring, maintenance, and sanitization services. The company was founded in 1904 and is headquartered in Radnor, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,692,300,000USD | 1,581,400,000USD | 1,663,600,000USD | 1,683,400,000USD | 1,581,400,000USD | 1,686,600,000USD | 1,714,400,000USD | 1,702,800,000USD |
| Cost Of Revenue | 1,155,300,000USD | 1,080,700,000USD | 1,139,700,000USD | 1,129,300,000USD | 1,046,500,000USD | 1,123,700,000USD | 1,150,000,000USD | 1,121,300,000USD |
| Gross Profit | 537,000,000USD | 500,700,000USD | 523,900,000USD | 554,100,000USD | 534,900,000USD | 562,900,000USD | 564,400,000USD | 581,500,000USD |
| Selling General Administrative | 415,200,000USD | 401,200,000USD | 392,400,000USD | 425,300,000USD | 387,500,000USD | 371,400,000USD | 439,800,000USD | 405,700,000USD |
| Total Operating Expenses | 415,200,000USD | 385,700,000USD | 397,500,000USD | 425,300,000USD | 387,500,000USD | -75,200,000USD | 439,800,000USD | 405,700,000USD |
| Operating Income | 121,800,000USD | 115,000,000USD | 126,400,000USD | 128,800,000USD | 147,400,000USD | 638,100,000USD | 124,600,000USD | 175,800,000USD |
| Total Other Income Expense Net | -40,600,000USD | -59,500,000USD | -45,600,000USD | -47,100,000USD | -61,700,000USD | -53,900,000USD | -50,100,000USD | -61,200,000USD |
| Interest Income | 10,300,000USD | — | — | — | — | — | — | — |
| Interest Expense | 39,400,000USD | 55,300,000USD | 40,000,000USD | 43,400,000USD | 42,200,000USD | 44,900,000USD | 48,700,000USD | 60,900,000USD |
| Income Before Tax | 81,200,000USD | 55,500,000USD | 80,800,000USD | 81,700,000USD | 85,700,000USD | 584,200,000USD | 74,500,000USD | 114,600,000USD |
| Income Tax Expense | 43,100,000USD | 12,200,000USD | 28,400,000USD | 17,000,000USD | 21,200,000USD | 83,800,000USD | 16,700,000USD | 21,700,000USD |
| Net Income | 38,100,000USD | 43,300,000USD | 52,400,000USD | 64,700,000USD | 64,500,000USD | 500,400,000USD | 57,800,000USD | 92,900,000USD |
| Net Income Applicable To Common Shares | 38,100,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | -15,500,000USD | 5,100,000USD | — | — | -446,600,000USD | — | — |
| Net Interest Income | — | -42,900,000USD | -40,000,000USD | -43,400,000USD | -42,200,000USD | -44,900,000USD | -48,700,000USD | -60,900,000USD |
| Tax Provision | — | 12,200,000USD | 28,400,000USD | 17,000,000USD | 21,200,000USD | 83,800,000USD | 16,700,000USD | 21,700,000USD |
| Net Income From Continuing Ops | — | 43,300,000USD | 52,400,000USD | 64,700,000USD | 64,500,000USD | 500,400,000USD | 57,800,000USD | 92,900,000USD |
| Ebit | — | 110,800,000USD | 120,800,000USD | 125,100,000USD | 127,900,000USD | 629,100,000USD | 123,200,000USD | 175,500,000USD |
| Ebitda | — | 215,800,000USD | 224,100,000USD | 227,800,000USD | 227,600,000USD | 730,000,000USD | 225,600,000USD | 278,100,000USD |
| Depreciation And Amortization | — | 105,000,000USD | 103,300,000USD | 102,700,000USD | 99,700,000USD | 100,900,000USD | 102,400,000USD | 102,600,000USD |
| Reconciled Depreciation | — | 105,000,000USD | 103,300,000USD | 102,700,000USD | 99,700,000USD | 100,900,000USD | 102,400,000USD | 102,600,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 6,783,600,000USD | 6,967,200,000USD | 7,386,100,000USD | 6,393,600,000USD | 6,040,300,000USD | 5,864,300,000USD |
| Cost Of Revenue | 4,504,300,000USD | 4,603,400,000USD | 4,883,400,000USD | 4,313,100,000USD | 4,119,600,000USD | 4,044,500,000USD |
| Gross Profit | 2,279,300,000USD | 2,363,800,000USD | 2,502,700,000USD | 2,080,500,000USD | 1,920,700,000USD | 1,819,800,000USD |
| Selling General Administrative | 1,641,100,000USD | 1,506,600,000USD | 1,530,500,000USD | 1,373,700,000USD | 1,368,900,000USD | 1,406,300,000USD |
| Unclassified Operating Expenses | -446,600,000USD | 160,800,000USD | — | — | — | — |
| Total Operating Expenses | 1,194,500,000USD | 1,667,400,000USD | 1,530,500,000USD | 1,373,700,000USD | 1,368,900,000USD | 1,406,300,000USD |
| Operating Income | 1,084,800,000USD | 696,400,000USD | 972,200,000USD | 706,800,000USD | 551,800,000USD | 413,500,000USD |
| Interest Expense | 218,800,000USD | 284,800,000USD | 217,400,000USD | 307,600,000USD | 440,000,000USD | 523,800,000USD |
| Net Interest Income | -218,800,000USD | -284,800,000USD | -217,400,000USD | -307,600,000USD | -440,000,000USD | -523,800,000USD |
| Income Before Tax | 853,900,000USD | 410,500,000USD | 753,000,000USD | 62,300,000USD | 40,600,000USD | -113,800,000USD |
| Income Tax Expense | 142,400,000USD | 89,400,000USD | 180,400,000USD | -54,300,000USD | 2,800,000USD | -26,900,000USD |
| Tax Provision | 142,400,000USD | 89,400,000USD | 180,400,000USD | -54,300,000USD | 2,800,000USD | -26,900,000USD |
| Net Income | 711,500,000USD | 321,100,000USD | 572,600,000USD | 116,600,000USD | 37,800,000USD | -86,900,000USD |
| Net Income From Continuing Ops | 711,500,000USD | 321,100,000USD | 572,600,000USD | 116,600,000USD | 37,800,000USD | -86,900,000USD |
| Ebit | 1,072,700,000USD | 695,300,000USD | 970,400,000USD | 369,900,000USD | 480,600,000USD | 410,000,000USD |
| Ebitda | 1,478,200,000USD | 1,097,600,000USD | 1,349,600,000USD | 765,300,000USD | 879,500,000USD | 814,600,000USD |
| Depreciation And Amortization | 405,500,000USD | 402,300,000USD | 379,200,000USD | 395,400,000USD | 398,900,000USD | 404,600,000USD |
| Reconciled Depreciation | 405,500,000USD | 402,300,000USD | 379,200,000USD | 395,400,000USD | 398,900,000USD | 404,600,000USD |
| Total Other Income Expense Net | -230,900,000USD | -285,900,000USD | -219,200,000USD | -644,500,000USD | -511,200,000USD | -527,300,000USD |
| Non Operating Income Net Other | — | — | -1,800,000USD | -336,900,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | 508,000,000USD | 52,000,000USD | -335,100,000USD | -356,400,000USD |
| Interest Income | — | — | — | — | 441,900,000USD | 530,300,000USD |
| Minority Interest | — | — | — | — | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,595,900,000USD | 11,663,000,000USD | 11,794,700,000USD | 11,675,900,000USD | 12,776,900,000USD | 12,326,400,000USD | 12,114,500,000USD | 12,840,600,000USD |
| Cash And Equivalents | 306,800,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 2,462,200,000USD | 2,404,300,000USD | 2,451,200,000USD | 2,257,200,000USD | 2,514,600,000USD | 2,282,400,000USD | 2,146,600,000USD | 2,504,700,000USD |
| Other Current Assets | 187,800,000USD | 209,900,000USD | 193,000,000USD | 132,100,000USD | 136,000,000USD | 120,300,000USD | 118,700,000USD | 352,100,000USD |
| Other Non Current Assets | 412,000,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 5,965,700,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 1,382,000,000USD | 1,367,300,000USD | 1,378,900,000USD | 1,516,500,000USD | 2,575,700,000USD | 2,034,400,000USD | 2,007,500,000USD | 1,629,800,000USD |
| Other Current Liabilities | 398,400,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 383,000,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 5,630,200,000USD | 5,588,700,000USD | 5,565,000,000USD | 5,570,200,000USD | 6,285,900,000USD | 6,098,200,000USD | 5,956,700,000USD | 5,553,200,000USD |
| Total Equity Including Noncontrolling Interest | 5,630,200,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 74,000,000USD | 37,000,000USD | 30,800,000USD | 219,800,000USD | 1,254,300,000USD | 827,500,000USD | 821,100,000USD | 229,700,000USD |
| Long Term Debt | 3,660,800,000USD | 3,779,300,000USD | 3,915,500,000USD | 3,638,100,000USD | 2,988,200,000USD | 3,279,200,000USD | 3,234,700,000USD | 4,691,400,000USD |
| Net Receivables | 1,138,900,000USD | 1,104,800,000USD | 1,074,600,000USD | 1,077,700,000USD | 1,149,400,000USD | 1,096,300,000USD | 1,034,500,000USD | 1,087,700,000USD |
| Inventory | 828,700,000USD | 810,300,000USD | 818,200,000USD | 795,500,000USD | 779,800,000USD | 750,100,000USD | 731,500,000USD | 779,600,000USD |
| Property Plant Equipment Net | 772,100,000USD | 766,200,000USD | 766,800,000USD | 761,600,000USD | 759,000,000USD | 736,300,000USD | 708,100,000USD | 722,800,000USD |
| Goodwill | 4,935,400,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 3,014,200,000USD | 3,098,700,000USD | 3,193,800,000USD | 3,266,700,000USD | 3,350,200,000USD | 3,331,100,000USD | 3,359,900,000USD | 3,522,700,000USD |
| Accounts Payable | 743,200,000USD | 735,500,000USD | 741,700,000USD | 691,600,000USD | 708,800,000USD | 680,100,000USD | 662,800,000USD | 673,500,000USD |
| Retained Earnings | 1,754,200,000USD | 1,716,100,000USD | 1,672,800,000USD | 1,620,400,000USD | 2,332,200,000USD | 2,267,500,000USD | 2,203,000,000USD | 1,702,600,000USD |
| Accumulated Other Comprehensive Income | -55,200,000USD | -43,700,000USD | -16,900,000USD | -23,600,000USD | -10,400,000USD | -117,700,000USD | -184,000,000USD | -73,900,000USD |
| Total Liab | — | 6,074,300,000USD | 6,229,700,000USD | 6,105,700,000USD | 6,491,000,000USD | 6,228,200,000USD | 6,157,800,000USD | 7,287,400,000USD |
| Other Current Liab | — | 594,800,000USD | 606,400,000USD | 605,100,000USD | 612,600,000USD | 526,800,000USD | 523,600,000USD | 726,600,000USD |
| Common Stock | — | 3,992,000,000USD | 3,984,800,000USD | 3,973,400,000USD | 3,964,100,000USD | 3,948,400,000USD | 3,937,700,000USD | 3,924,500,000USD |
| Capital Stock | — | 3,992,000,000USD | 3,984,800,000USD | 3,973,400,000USD | 3,964,100,000USD | 3,948,400,000USD | 3,937,700,000USD | 3,924,500,000USD |
| Good Will | — | 4,952,100,000USD | 4,986,900,000USD | 4,984,700,000USD | 5,762,200,000USD | 5,609,100,000USD | 5,539,200,000USD | 5,670,600,000USD |
| Cash | — | 279,300,000USD | 365,400,000USD | 251,900,000USD | 449,400,000USD | 315,700,000USD | 261,900,000USD | 285,300,000USD |
| Cash And Short Term Investments | — | 279,300,000USD | 365,400,000USD | 251,900,000USD | 449,400,000USD | 315,700,000USD | 261,900,000USD | 285,300,000USD |
| Net Debt | — | 3,537,000,000USD | 3,580,900,000USD | 3,606,000,000USD | 3,793,100,000USD | 3,791,000,000USD | 3,793,900,000USD | 4,635,800,000USD |
| Short Term Debt | — | 37,000,000USD | 30,800,000USD | 219,800,000USD | 1,254,300,000USD | 827,500,000USD | 821,100,000USD | 229,700,000USD |
| Short Long Term Debt Total | — | 3,816,300,000USD | 3,946,300,000USD | 3,857,900,000USD | 4,242,500,000USD | 4,106,700,000USD | 4,055,800,000USD | 4,921,100,000USD |
| Property Plant Equipment Gross | — | 1,531,700,000USD | 1,511,500,000USD | 1,485,500,000USD | 1,458,700,000USD | 1,399,700,000USD | 1,337,600,000USD | 1,343,700,000USD |
| Common Stock Shares Outstanding | — | 679,300,000shares | 679,300,000shares | 681,700,000shares | 681,800,000shares | 682,400,000shares | 682,700,000shares | 683,000,000shares |
| Non Current Assets Total | — | 9,258,700,000USD | 9,343,500,000USD | 9,418,700,000USD | 10,262,300,000USD | 10,044,000,000USD | 9,967,600,000USD | 10,335,900,000USD |
| Non Current Liabilities Total | — | 4,707,000,000USD | 4,850,800,000USD | 4,589,200,000USD | 3,915,300,000USD | 4,193,800,000USD | 4,150,300,000USD | 5,657,600,000USD |
| Non Current Liabilities Other | — | 377,300,000USD | 378,200,000USD | 402,600,000USD | 391,400,000USD | 364,600,000USD | 358,300,000USD | 418,900,000USD |
| Non Currrent Assets Other | — | 441,700,000USD | 396,000,000USD | 405,700,000USD | 390,900,000USD | 367,500,000USD | 360,400,000USD | 419,800,000USD |
| Net Working Capital | — | 1,037,000,000USD | 1,072,300,000USD | 740,700,000USD | -61,100,000USD | 248,000,000USD | 139,100,000USD | 874,900,000USD |
| Unclassified Current Liabilities | — | -37,000,000USD | -30,800,000USD | -219,800,000USD | -1,254,300,000USD | -827,500,000USD | -821,100,000USD | -269,600,000USD |
| Unclassified Non Current Liabilities | — | 550,400,000USD | 557,100,000USD | 548,500,000USD | 535,700,000USD | 550,000,000USD | 557,300,000USD | 547,300,000USD |
| Unclassified Equity | — | -4,067,700,000USD | -4,060,500,000USD | -3,973,400,000USD | -3,964,100,000USD | -3,948,400,000USD | -3,937,700,000USD | -3,924,500,000USD |
| Other Assets | — | — | — | — | — | — | 300,000USD | — |
| Current Deferred Revenue | — | — | — | — | — | — | — | 39,900,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 11,794,700,000USD | 12,114,500,000USD | 12,972,700,000USD | 13,464,300,000USD | 13,897,200,000USD | 9,906,500,000USD | 9,773,300,000USD | 9,911,600,000USD |
| Intangible Assets | 3,193,800,000USD | 3,359,900,000USD | 3,775,300,000USD | 4,133,300,000USD | 5,140,300,000USD | 4,048,800,000USD | 4,220,200,000USD | 4,565,700,000USD |
| Other Current Assets | 193,000,000USD | 118,700,000USD | 143,700,000USD | 153,100,000USD | 81,400,000USD | 91,400,000USD | 134,800,000USD | 112,600,000USD |
| Total Liab | 6,229,700,000USD | 6,157,800,000USD | 7,720,100,000USD | 8,608,900,000USD | 9,700,200,000USD | 7,232,200,000USD | 7,311,100,000USD | 12,963,300,000USD |
| Total Stockholder Equity | 5,565,000,000USD | 5,956,700,000USD | 5,252,600,000USD | 4,855,400,000USD | 4,197,000,000USD | 2,674,300,000USD | 2,462,200,000USD | -3,051,700,000USD |
| Other Current Liab | 606,400,000USD | 523,600,000USD | 594,500,000USD | 536,400,000USD | 650,500,000USD | 537,400,000USD | 420,800,000USD | 396,400,000USD |
| Common Stock | 3,984,800,000USD | 3,937,700,000USD | 3,830,100,000USD | 3,785,300,000USD | 2,752,600,000USD | 1,737,600,000USD | 1,748,100,000USD | -2,746,800,000USD |
| Capital Stock | 3,984,800,000USD | 3,937,700,000USD | 3,830,100,000USD | 3,785,300,000USD | 3,756,300,000USD | 2,741,300,000USD | 2,751,800,000USD | -2,746,800,000USD |
| Retained Earnings | 1,672,800,000USD | 2,203,000,000USD | 1,491,500,000USD | 1,170,400,000USD | 483,900,000USD | -88,700,000USD | -203,700,000USD | -238,400,000USD |
| Good Will | 4,986,900,000USD | 5,539,200,000USD | 5,716,700,000USD | 5,652,600,000USD | 5,341,100,000USD | 2,860,200,000USD | 2,769,400,000USD | 2,784,700,000USD |
| Cash | 365,400,000USD | 261,900,000USD | 262,900,000USD | 372,900,000USD | 301,700,000USD | 286,600,000USD | 186,700,000USD | 184,700,000USD |
| Cash And Short Term Investments | 365,400,000USD | 261,900,000USD | 262,900,000USD | 372,900,000USD | 301,700,000USD | 286,600,000USD | 186,700,000USD | 184,700,000USD |
| Total Current Assets | 2,451,200,000USD | 2,146,600,000USD | 2,384,900,000USD | 2,657,900,000USD | 2,477,200,000USD | 2,230,900,000USD | 2,021,500,000USD | 1,899,600,000USD |
| Total Current Liabilities | 1,378,900,000USD | 2,007,500,000USD | 1,480,300,000USD | 1,658,800,000USD | 1,450,800,000USD | 1,242,700,000USD | 1,074,500,000USD | 1,096,200,000USD |
| Net Debt | 3,580,900,000USD | 3,793,900,000USD | 5,273,700,000USD | 5,914,600,000USD | 6,721,500,000USD | 4,607,300,000USD | 4,929,800,000USD | 6,740,000,000USD |
| Short Term Debt | 30,800,000USD | 821,100,000USD | 259,900,000USD | 364,200,000USD | 45,200,000USD | 26,400,000USD | 93,500,000USD | 142,400,000USD |
| Short Long Term Debt | 30,800,000USD | 821,100,000USD | 259,900,000USD | 364,200,000USD | 45,200,000USD | 26,400,000USD | 93,500,000USD | 142,400,000USD |
| Short Long Term Debt Total | 3,946,300,000USD | 4,055,800,000USD | 5,536,600,000USD | 6,287,500,000USD | 7,023,200,000USD | 4,893,900,000USD | 5,116,500,000USD | 6,924,700,000USD |
| Long Term Debt | 3,915,500,000USD | 3,234,700,000USD | 5,276,700,000USD | 5,923,300,000USD | 6,978,000,000USD | 4,867,500,000USD | 5,023,000,000USD | 6,782,300,000USD |
| Net Receivables | 1,074,600,000USD | 1,034,500,000USD | 1,150,200,000USD | 1,218,400,000USD | 1,222,100,000USD | 1,113,300,000USD | 988,800,000USD | 931,200,000USD |
| Inventory | 818,200,000USD | 731,500,000USD | 828,100,000USD | 913,500,000USD | 872,000,000USD | 739,600,000USD | 711,200,000USD | 671,100,000USD |
| Accounts Payable | 741,700,000USD | 662,800,000USD | 625,900,000USD | 758,200,000USD | 755,100,000USD | 678,900,000USD | 560,200,000USD | 557,400,000USD |
| Property Plant Equipment Net | 766,800,000USD | 708,100,000USD | 737,500,000USD | 727,000,000USD | 705,500,000USD | 549,900,000USD | 557,000,000USD | 598,600,000USD |
| Property Plant Equipment Gross | 1,511,500,000USD | 1,337,600,000USD | 1,354,400,000USD | 1,245,400,000USD | 1,150,700,000USD | 549,000,000USD | 557,000,000USD | 598,600,000USD |
| Accumulated Other Comprehensive Income | -16,900,000USD | -184,000,000USD | -69,000,000USD | -100,300,000USD | -43,200,000USD | 21,700,000USD | -85,900,000USD | -66,500,000USD |
| Common Stock Shares Outstanding | 679,300,000shares | 681,900,000shares | 678,400,000shares | 679,400,000shares | 599,600,000shares | 583,400,000shares | 401,200,000shares | 496,500,000shares |
| Non Current Assets Total | 9,343,500,000USD | 9,967,600,000USD | 10,587,800,000USD | 10,806,400,000USD | 11,420,000,000USD | 7,675,600,000USD | 7,751,800,000USD | 8,012,000,000USD |
| Non Current Liabilities Total | 4,850,800,000USD | 4,150,300,000USD | 6,239,800,000USD | 6,950,100,000USD | 8,249,400,000USD | 5,989,500,000USD | 6,236,600,000USD | 11,867,100,000USD |
| Non Current Liabilities Other | 378,200,000USD | 358,300,000USD | 350,300,000USD | 295,400,000USD | 358,400,000USD | 398,100,000USD | 428,200,000USD | 318,000,000USD |
| Non Currrent Assets Other | 396,000,000USD | 360,400,000USD | 358,300,000USD | 293,500,000USD | 233,100,000USD | 216,700,000USD | 205,200,000USD | 63,000,000USD |
| Net Working Capital | 1,072,300,000USD | 139,100,000USD | 904,600,000USD | 999,100,000USD | 1,026,400,000USD | 988,200,000USD | 947,000,000USD | 803,400,000USD |
| Unclassified Current Liabilities | -30,800,000USD | -821,100,000USD | -443,200,000USD | -1,095,600,000USD | -294,700,000USD | -250,200,000USD | -282,000,000USD | -363,900,000USD |
| Unclassified Non Current Liabilities | 557,100,000USD | 557,300,000USD | 612,800,000USD | -940,200,000USD | -1,271,400,000USD | -1,023,800,000USD | -321,600,000USD | 3,541,300,000USD |
| Unclassified Equity | -4,060,500,000USD | -3,937,700,000USD | -3,830,100,000USD | -3,785,300,000USD | -2,752,600,000USD | -1,737,600,000USD | -1,748,100,000USD | 2,746,800,000USD |
| Other Assets | — | 300,000USD | — | 174,800,000USD | 233,100,000USD | 219,000,000USD | 72,900,000USD | 63,000,000USD |
| Current Deferred Revenue | — | — | 183,300,000USD | 731,400,000USD | 249,500,000USD | 223,800,000USD | 188,500,000USD | 221,500,000USD |
| Short Term Investments | — | — | 16,600,000USD | 26,200,000USD | — | — | — | — |
| Deferred Long Term Liab | — | — | — | 731,400,000USD | 913,000,000USD | 723,900,000USD | — | — |
| Other Liab | — | — | — | 940,200,000USD | 1,271,400,000USD | 1,023,800,000USD | 1,107,000,000USD | 1,225,500,000USD |
| Net Tangible Assets | — | — | — | -4,930,500,000USD | -7,288,100,000USD | -5,238,400,000USD | -5,531,100,000USD | -10,402,100,000USD |
| Unclassified Non Current Assets | — | — | — | -174,800,000USD | -233,100,000USD | -219,000,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 210,600,000USD |
| Stock Based Compensation | 24,000,000USD |
| Deferred Income Tax | 6,100,000USD |
| Other Non Cash Items | -2,500,000USD |
| Change To Account Receivables | -80,700,000USD |
| Change To Inventory | -46,700,000USD |
| Change In Working Capital | -127,400,000USD |
| Operating Cash Flow | 236,900,000USD |
| Capital Expenditures | -71,100,000USD |
| Other Investing Activities | -1,100,000USD |
| Unclassified Investing Cash Flow | 2,200,000USD |
| Investing Cash Flow | -70,000,000USD |
| Net Debt Issuance | -220,700,000USD |
| Net Common Stock Issuance | -3,900,000USD |
| Other Financing Activities | -100,000USD |
| Unclassified Financing Cash Flow | 5,100,000USD |
| Financing Cash Flow | -219,600,000USD |
| Effect Of Forex Changes On Cash | -5,900,000USD |
| Change In Cash | -58,600,000USD |
| End Cash Flow | 309,700,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 43,300,000USD | 52,400,000USD | -711,800,000USD | 64,700,000USD | 64,500,000USD | 500,400,000USD | 57,800,000USD | 92,900,000USD |
| Depreciation | 105,000,000USD | 103,300,000USD | 104,500,000USD | 102,700,000USD | 99,700,000USD | 100,900,000USD | 102,400,000USD | 102,600,000USD |
| Stock Based Compensation | 8,600,000USD | 11,300,000USD | 7,200,000USD | 15,500,000USD | 12,400,000USD | 11,100,000USD | 11,900,000USD | 11,100,000USD |
| Other Non Cash Items | 12,400,000USD | 33,600,000USD | 799,400,000USD | 19,500,000USD | 36,100,000USD | -414,100,000USD | 32,000,000USD | 19,400,000USD |
| Change To Account Receivables | -40,800,000USD | 3,100,000USD | 66,200,000USD | -12,500,000USD | -43,200,000USD | 11,700,000USD | 34,200,000USD | -2,700,000USD |
| Change To Inventory | -12,200,000USD | -42,700,000USD | -33,400,000USD | -15,700,000USD | -17,600,000USD | 3,000,000USD | -7,300,000USD | -3,200,000USD |
| Change In Working Capital | -100,400,000USD | -97,500,000USD | 20,000,000USD | -30,400,000USD | -91,000,000USD | -53,400,000USD | 63,300,000USD | 89,900,000USD |
| Total Cash From Operating Activities | 58,700,000USD | 152,700,000USD | 207,400,000USD | 154,400,000USD | 109,300,000USD | 173,300,000USD | 244,800,000USD | 281,100,000USD |
| Capital Expenditures | -33,500,000USD | -35,500,000USD | -35,700,000USD | -29,600,000USD | -28,000,000USD | -27,500,000USD | -40,800,000USD | -45,800,000USD |
| Free Cash Flow | 25,200,000USD | 117,200,000USD | 171,700,000USD | 124,800,000USD | 81,300,000USD | 145,800,000USD | 204,000,000USD | 235,300,000USD |
| Total Cashflows From Investing Activities | -32,700,000USD | -39,700,000USD | -33,300,000USD | -28,600,000USD | -28,900,000USD | 558,500,000USD | -40,500,000USD | -44,900,000USD |
| Net Borrowings | -105,400,000USD | 90,900,000USD | -371,500,000USD | -6,800,000USD | -31,300,000USD | -756,800,000USD | -214,300,000USD | — |
| Total Cash From Financing Activities | -107,200,000USD | 700,000USD | -369,600,000USD | -6,900,000USD | -33,600,000USD | -755,300,000USD | -198,600,000USD | -197,100,000USD |
| Sale Purchase Of Stock | -3,600,000USD | -75,300,000USD | -400,000USD | -100,000USD | -4,900,000USD | -400,000USD | -800,000USD | -800,000USD |
| Change In Cash | -86,100,000USD | 113,600,000USD | -197,500,000USD | 133,300,000USD | 53,800,000USD | -45,600,000USD | 13,600,000USD | 37,500,000USD |
| Begin Period Cash Flow | 368,300,000USD | 254,700,000USD | 452,200,000USD | 318,900,000USD | 264,700,000USD | 310,300,000USD | 296,700,000USD | 234,900,000USD |
| End Period Cash Flow | 282,200,000USD | 368,300,000USD | 254,700,000USD | 452,200,000USD | 318,500,000USD | 264,700,000USD | 310,300,000USD | 272,600,000USD |
| Other Cashflows From Investing Activities | 800,000USD | -4,200,000USD | 2,400,000USD | 1,000,000USD | -900,000USD | 586,000,000USD | 300,000USD | 900,000USD |
| Other Cashflows From Financing Activities | -100,000USD | -15,100,000USD | 2,300,000USD | -100,000USD | 2,600,000USD | 1,900,000USD | 16,500,000USD | 5,300,000USD |
| Unclassified Operating Cash Flow | -10,200,000USD | 49,600,000USD | -11,900,000USD | -17,600,000USD | -12,400,000USD | 28,400,000USD | -22,600,000USD | -34,800,000USD |
| Unclassified Financing Cash Flow | 1,900,000USD | — | — | — | — | — | — | -201,600,000USD |
| Investments | — | — | -33,300,000USD | -28,600,000USD | -28,900,000USD | 558,500,000USD | -40,500,000USD | -44,900,000USD |
| Unclassified Investing Cash Flow | — | — | 33,300,000USD | 28,600,000USD | 28,900,000USD | -558,500,000USD | 40,500,000USD | 44,900,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -530,200,000USD | 711,500,000USD | 321,100,000USD | 686,500,000USD | 572,600,000USD | 116,600,000USD | 37,800,000USD | -86,900,000USD |
| Depreciation | 410,200,000USD | 405,500,000USD | 402,300,000USD | 405,500,000USD | 379,200,000USD | 395,400,000USD | 398,900,000USD | 404,600,000USD |
| Stock Based Compensation | 46,400,000USD | 46,800,000USD | 40,500,000USD | 45,800,000USD | 50,700,000USD | 44,100,000USD | 67,900,000USD | 18,400,000USD |
| Other Non Cash Items | 888,600,000USD | -323,800,000USD | 261,900,000USD | 96,200,000USD | 83,300,000USD | 441,700,000USD | 142,700,000USD | 97,900,000USD |
| Change To Account Receivables | 13,600,000USD | 45,900,000USD | 77,000,000USD | -45,200,000USD | -111,800,000USD | -102,400,000USD | -68,900,000USD | -83,400,000USD |
| Change To Inventory | -109,400,000USD | -18,500,000USD | 30,300,000USD | -112,500,000USD | -129,800,000USD | -69,700,000USD | -71,100,000USD | -41,100,000USD |
| Change In Working Capital | -198,900,000USD | 47,700,000USD | 16,600,000USD | -321,300,000USD | -114,500,000USD | 19,500,000USD | -186,600,000USD | -93,800,000USD |
| Total Cash From Operating Activities | 623,800,000USD | 840,800,000USD | 870,000,000USD | 843,600,000USD | 953,600,000USD | 929,800,000USD | 354,000,000USD | 200,500,000USD |
| Capital Expenditures | -128,800,000USD | -148,800,000USD | -146,400,000USD | -133,400,000USD | -111,100,000USD | -61,600,000USD | -51,600,000USD | -37,700,000USD |
| Free Cash Flow | 495,000,000USD | 692,000,000USD | 723,600,000USD | 710,200,000USD | 842,500,000USD | 868,200,000USD | 302,400,000USD | 162,800,000USD |
| Total Cashflows From Investing Activities | -130,500,000USD | 438,900,000USD | -143,700,000USD | -109,600,000USD | -4,121,700,000USD | -59,100,000USD | -42,100,000USD | -23,200,000USD |
| Net Borrowings | -318,700,000USD | -1,341,800,000USD | -846,000,000USD | -620,400,000USD | 2,300,700,000USD | -738,500,000USD | -1,877,300,000USD | -149,800,000USD |
| Total Cash From Financing Activities | -409,400,000USD | -1,281,200,000USD | -843,700,000USD | -648,700,000USD | 3,219,200,000USD | -782,900,000USD | -307,800,000USD | -170,300,000USD |
| Sale Purchase Of Stock | -80,700,000USD | -8,600,000USD | -13,700,000USD | -13,200,000USD | -25,800,000USD | -16,200,000USD | -2,630,900,000USD | — |
| Change In Cash | 103,600,000USD | -23,000,000USD | -109,200,000USD | 69,800,000USD | 37,900,000USD | 99,900,000USD | 1,600,000USD | -800,000USD |
| Begin Period Cash Flow | 264,700,000USD | 287,700,000USD | 396,900,000USD | 327,100,000USD | 289,200,000USD | 189,300,000USD | 187,700,000USD | 188,500,000USD |
| End Period Cash Flow | 368,300,000USD | 264,700,000USD | 287,700,000USD | 396,900,000USD | 327,100,000USD | 289,200,000USD | 189,300,000USD | 187,700,000USD |
| Other Cashflows From Investing Activities | -1,700,000USD | 587,700,000USD | 2,700,000USD | -18,700,000USD | 3,500,000USD | 2,500,000USD | 9,500,000USD | 14,500,000USD |
| Other Cashflows From Financing Activities | -15,100,000USD | 69,200,000USD | 16,000,000USD | 343,900,000USD | 2,876,500,000USD | 3,643,200,000USD | -2,600,000USD | -20,500,000USD |
| Unclassified Operating Cash Flow | 7,700,000USD | -46,900,000USD | -172,400,000USD | -69,100,000USD | -17,700,000USD | -87,500,000USD | -106,700,000USD | -139,700,000USD |
| Unclassified Financing Cash Flow | 5,100,000USD | — | 18,300,000USD | -326,600,000USD | -1,867,600,000USD | -3,606,800,000USD | 4,234,300,000USD | 31,300,000USD |
| Investments | — | 438,900,000USD | -126,800,000USD | -109,600,000USD | -4,121,700,000USD | -59,100,000USD | -42,100,000USD | -23,200,000USD |
| Dividends Paid | — | 0USD | -18,300,000USD | -32,400,000USD | -64,600,000USD | -64,600,000USD | -31,300,000USD | -31,300,000USD |
| Unclassified Investing Cash Flow | — | -438,900,000USD | 126,800,000USD | 152,100,000USD | 107,600,000USD | 59,100,000USD | 42,100,000USD | 23,200,000USD |
| Issuance Of Capital Stock | — | — | 0USD | 0USD | 967,000,000USD | 0USD | 4,235,600,000USD | 0USD |
| Change To Liabilities | — | — | — | 15,700,000USD | 64,900,000USD | 80,900,000USD | -2,000,000USD | 34,200,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 85,300,000USD | 51,100,000USD | 87,800,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Proprietary Materials And Consumables | 880,400,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Third Party Materials And Consumables | 811,900,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Bioscience Medtech Products | 451,800,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | VWRDistribution Services | 1,240,500,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Proprietary Materials And Consumables | 833,300,000 | USD | 0001628280-26-028141 |
| Q1 2026Quarterly · 2026-03-31 | Product | Third Party Materials And Consumables | 748,100,000 | USD | 0001628280-26-028141 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Bioscience Medtech Products | 431,400,000 | USD | 0001628280-26-028141 |
| Q1 2026Quarterly · 2026-03-31 | Segment | VWRDistribution Services | 1,150,000,000 | USD | 0001628280-26-028141 |
| Q4 2025Quarterly · 2025-12-31 | Product | Proprietary Materials And Consumables | 869,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Third Party Materials And Consumables | 793,800,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Bioscience Production | 547,500,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Laboratory Solutions | 1,116,100,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Product | Proprietary Materials And Consumables | 3,448,900,000 | USD | 0001628280-26-007118 |
| FY 2025Yearly · 2025-12-31 | Product | Third Party Materials And Consumables | 3,103,300,000 | USD | 0001628280-26-007118 |
| FY 2025Yearly · 2025-12-31 | Segment | Bioscience Production | 2,152,500,000 | USD | 0001628280-26-007118 |
| FY 2025Yearly · 2025-12-31 | Segment | Laboratory Solutions | 4,399,700,000 | USD | 0001628280-26-007118 |
| Q3 2025Quarterly · 2025-09-30 | Product | Proprietary Materials And Consumables | 855,600,000 | USD | 0001628280-25-046936 |
| Q3 2025Quarterly · 2025-09-30 | Product | Third Party Materials And Consumables | 768,200,000 | USD | 0001628280-25-046936 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Bioscience Production | 527,300,000 | USD | 0001628280-25-046936 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Laboratory Solutions | 1,096,500,000 | USD | 0001628280-25-046936 |
| Q2 2025Quarterly · 2025-06-30 | Product | Proprietary Materials And Consumables | 893,800,000 | USD | 0001722482-25-000190 |
| Q2 2025Quarterly · 2025-06-30 | Product | Third Party Materials And Consumables | 789,600,000 | USD | 0001722482-25-000190 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Bioscience Production | 561,300,000 | USD | 0001722482-25-000190 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Laboratory Solutions | 1,122,100,000 | USD | 0001722482-25-000190 |
| Q1 2025Quarterly · 2025-03-31 | Product | Proprietary Materials And Consumables | 829,700,000 | USD | 0001628280-26-028141 |
| Q1 2025Quarterly · 2025-03-31 | Product | Third Party Materials And Consumables | 751,700,000 | USD | 0001628280-26-028141 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Bioscience Medtech Products | 426,400,000 | USD | 0001628280-26-028141 |
| Q1 2025Quarterly · 2025-03-31 | Segment | VWRDistribution Services | 1,155,000,000 | USD | 0001628280-26-028141 |
| Q4 2024Quarterly · 2024-12-31 | Product | Proprietary Materials And Consumables | 897,100,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Third Party Materials And Consumables | 789,500,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Bioscience Production | 560,800,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Laboratory Solutions | 1,125,800,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Product | Proprietary Materials And Consumables | 3,615,100,000 | USD | 0001628280-26-007118 |
| FY 2024Yearly · 2024-12-31 | Product | Third Party Materials And Consumables | 3,168,500,000 | USD | 0001628280-26-007118 |
| FY 2024Yearly · 2024-12-31 | Segment | Bioscience Production | 2,173,500,000 | USD | 0001628280-26-007118 |
| FY 2024Yearly · 2024-12-31 | Segment | Laboratory Solutions | 4,610,100,000 | USD | 0001628280-26-007118 |
| Q3 2024Quarterly · 2024-09-30 | Product | Proprietary Materials And Consumables | 920,500,000 | USD | 0001628280-25-046936 |
| Q3 2024Quarterly · 2024-09-30 | Product | Third Party Materials And Consumables | 793,900,000 | USD | 0001628280-25-046936 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Bioscience Production | 542,900,000 | USD | 0001628280-25-046936 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Laboratory Solutions | 1,171,500,000 | USD | 0001628280-25-046936 |
| FY 2023Yearly · 2023-12-31 | Product | Equipment And Instrumentation | 928,000,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Proprietary Materials And Consumables | 2,538,400,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Services And Specialty Procurement | 963,500,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Product | Third Party Materials And Consumables | 2,537,300,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Segment | Bioscience Production | 2,228,900,000 | USD | 0001628280-26-007118 |
| FY 2023Yearly · 2023-12-31 | Segment | Laboratory Solutions | 4,738,300,000 | USD | 0001628280-26-007118 |
| Q4 2023Quarterly · 2023-12-31 | Geography | Americas | 994,800,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Geography | Europe | 603,500,000 | USD | Legacy provider |
| Q4 2023Quarterly · 2023-12-31 | Geography | Other | 124,500,000 | USD | Legacy provider |
| FY 2023Yearly · 2023-12-31 | Geography | Americas | 4,071,600,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 2,420,400,000 | USD | 0001722482-24-000012 |
| FY 2023Yearly · 2023-12-31 | Geography | Other | 475,200,000 | USD | 0001722482-24-000012 |
| Q3 2023Quarterly · 2023-09-30 | Geography | Americas | 1,019,200,000 | USD | 0001722482-23-000199 |
| Q3 2023Quarterly · 2023-09-30 | Geography | Europe | 579,800,000 | USD | 0001722482-23-000199 |
| Q3 2023Quarterly · 2023-09-30 | Geography | Other | 121,200,000 | USD | 0001722482-23-000199 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Americas | 1,025,600,000 | USD | 0001722482-23-000159 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Europe | 606,900,000 | USD | 0001722482-23-000159 |
| Q2 2023Quarterly · 2023-06-30 | Geography | Other | 111,400,000 | USD | 0001722482-23-000159 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Americas | 1,032,000,000 | USD | 0001722482-23-000100 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Europe | 630,200,000 | USD | 0001722482-23-000100 |
| Q1 2023Quarterly · 2023-03-31 | Geography | Other | 118,100,000 | USD | 0001722482-23-000100 |
| FY 2022Yearly · 2022-12-31 | Product | Equipment And Instrumentation | 988,900,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Proprietary Materials And Consumables | 2,898,400,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Services And Specialty Procurement | 921,000,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Product | Third Party Materials And Consumables | 2,704,100,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Segment | Bioscience Production | 2,510,000,000 | USD | 0001722482-25-000015 |
| FY 2022Yearly · 2022-12-31 | Segment | Laboratory Solutions | 5,002,400,000 | USD | 0001722482-25-000015 |
| Q4 2022Quarterly · 2022-12-31 | Geography | Americas | 1,048,000,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Geography | Europe | 617,200,000 | USD | Legacy provider |
| Q4 2022Quarterly · 2022-12-31 | Geography | Other | 129,800,000 | USD | Legacy provider |
| FY 2022Yearly · 2022-12-31 | Geography | Americas | 4,471,200,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 2,516,500,000 | USD | 0001722482-24-000012 |
| FY 2022Yearly · 2022-12-31 | Geography | Other | 524,700,000 | USD | 0001722482-24-000012 |
| Q3 2022Quarterly · 2022-09-30 | Geography | Americas | 1,123,200,000 | USD | 0001722482-23-000199 |
| Q3 2022Quarterly · 2022-09-30 | Geography | Europe | 595,100,000 | USD | 0001722482-23-000199 |
| Q3 2022Quarterly · 2022-09-30 | Geography | Other | 138,200,000 | USD | 0001722482-23-000199 |
| Q2 2022Quarterly · 2022-06-30 | Geography | Americas | 1,156,600,000 | USD | 0001722482-23-000159 |
| Q2 2022Quarterly · 2022-06-30 | Geography | Europe | 623,800,000 | USD | 0001722482-23-000159 |
| Q2 2022Quarterly · 2022-06-30 | Geography | Other | 130,100,000 | USD | 0001722482-23-000159 |
| Q1 2022Quarterly · 2022-03-31 | Geography | Americas | 1,143,400,000 | USD | 0001722482-23-000100 |
| Q1 2022Quarterly · 2022-03-31 | Geography | Europe | 680,400,000 | USD | 0001722482-23-000100 |
| Q1 2022Quarterly · 2022-03-31 | Geography | Other | 126,600,000 | USD | 0001722482-23-000100 |
| FY 2021Yearly · 2021-12-31 | Product | Equipment And Instrumentation | 1,009,000,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Proprietary Materials And Consumables | 2,548,200,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Services And Specialty Procurement | 922,600,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Product | Third Party Materials And Consumables | 2,906,300,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Geography | Americas | 4,237,400,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 2,677,300,000 | USD | 0001722482-24-000012 |
| FY 2021Yearly · 2021-12-31 | Geography | Other | 471,400,000 | USD | 0001722482-24-000012 |
| FY 2020Yearly · 2020-12-31 | Product | Equipment And Instrumentation | 860,700,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Product | Proprietary Materials And Consumables | 2,043,600,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Product | Services And Specialty Procurement | 817,500,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Product | Third Party Materials And Consumables | 2,671,800,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Geography | Americas | 3,731,500,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 2,286,700,000 | USD | 0001722482-23-000040 |
| FY 2020Yearly · 2020-12-31 | Geography | Other | 375,400,000 | USD | 0001722482-23-000040 |
| FY 2019Yearly · 2019-12-31 | Product | Equipment And Instrumentation | 912,400,000 | USD | 0001722482-22-000030 |
| FY 2019Yearly · 2019-12-31 | Product | Proprietary Materials And Consumables | 1,765,400,000 | USD | 0001722482-22-000030 |
| FY 2019Yearly · 2019-12-31 | Product | Services And Specialty Procurement | 778,900,000 | USD | 0001722482-22-000030 |
| FY 2019Yearly · 2019-12-31 | Product | Third Party Materials And Consumables | 2,583,600,000 | USD | 0001722482-22-000030 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.